The estimated Net Worth of Stuart Kolinski is at least $26.5 Million dollars as of 3 June 2010. Stuart Kolinski owns over 12,500 units of Regeneron Pharmaceuticals stock worth over $26,382,334 and over the last 21 years Stuart sold REGN stock worth over $150,281.
Stuart has made over 10 trades of the Regeneron Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Stuart exercised 12,500 units of REGN stock worth $106,250 on 3 June 2010.
The largest trade Stuart's ever made was exercising 12,500 units of Regeneron Pharmaceuticals stock on 3 June 2010 worth over $106,250. On average, Stuart trades about 2,622 units every 123 days since 2003. As of 3 June 2010 Stuart still owns at least 23,113 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Stuart Kolinski stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: